MU001 (Universidad de Chile)

MU001 is a topical therapeutic formulation developed by the University of Chile, consisting of a combination of snail slime (*Helix aspersa Müller*), calendula, and propolis. It is administered via a patch for the treatment of Wagner grade 1-2 diabetic foot ulcers in patients with type 2 diabetes. The formulation aims to accelerate wound healing through the synergistic actions of its natural components: snail slime provides regenerative proteins and glycosaminoglycans to facilitate tissue repair, calendula offers anti-inflammatory and antioxidant properties, and propolis serves as a natural antimicrobial agent to prevent infection. A Phase I/II clinical trial has been conducted to evaluate the efficacy and safety of MU001 patches compared to the standard of care for chronic diabetic wounds.

Other names

Snail Slime and Natural ExtractsHelix aspersa Müller and natural extracts